All Members Community

 View Only

FW: Research!America Statement on Senate Continuing Resolution Praises Delay in OMB Rule

  • 1.  FW: Research!America Statement on Senate Continuing Resolution Praises Delay in OMB Rule

    Posted 4 days ago

    August 3, 2026

     

    ABRF Members,

     

    See below for potentially positive developments in response to OMB rule proposal.....

     

    ABRF will continue to share updates as they become available.

     

     

     

     

    From: Research!America News <editor@researchamerica.org>
    Sent: Sunday, August 2, 2026 5:06 PM
    To: Ken Schoppmann <ken.schoppmann@abrf.org>
    Subject: Research!America Statement on Senate Continuing Resolution Praises Delay in OMB Rule

     

    Research!America Statement on Senate Continuing Resolution Praises Delay in OMB Rule

     

     

    Research!America Statement on Senate Continuing Resolution Praises Delay in OMB Rule

     

    ARLINGTON, Va. (Aug. 2, 2026) – Research!America, the nation's largest multi-sector alliance advancing medical research to achieve better health and well-being for all, released the following statement following the release Sunday of a Senate Continuing Resolution (CR) that delays implementation of a proposed Office of Management and Budget (OMB) rule through Dec. 11:

    "We are truly grateful for the bipartisan language that would delay the OMB's sweeping proposed changes to federal grantmaking," said Research!America President and CEO Russ Paulsen. "Across the country, individuals and groups representing medical research, agriculture, law enforcement, transportation, housing, and others have sounded the alarm on this proposed rule's destructive impact on key priorities of the American people. This delay helps ensure OMB takes those concerns seriously and goes back to the drawing board. 

    "Congress now needs to pass this version of the CR. It would not only keep the government open, but it would safeguard scientific progress. If it were finalized, OMB's rule would allow for the termination of grants – including clinical trials – midstream, without any right to appeal. It would give the OMB centralized control over the grantmaking process. Unelected bureaucrats could subvert congressional intent and award or terminate grants based on their own political or ideological goals, not scientific merit. This proposed rule would set back medical research in this nation, delaying treatment and cures for American patients."

     

    Contact Glenn O'Neal, Senior Director of Communications, at 571-482-2737 or goneal@researchamerica.org with press inquiries.  

     

    ###

     

    About Research!America 
    Research!America is a non-profit medical and health research advocacy alliance which advocates for science, discovery, and innovation to achieve better health for all. For over 30 years, Research!America has been commissioning surveys to help understand public support for medical, health, and scientific research, among other state, national, and global issues related to public health and research and innovation. Visit www.researchamerica.org

     

    Unsubscribe

    Powered by